Harmony Biosciences Holdings (HRMY) Enterprise Value (2019 - 2025)
Historic Enterprise Value for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to -$672.6 million.
- Harmony Biosciences Holdings' Enterprise Value fell 5397.07% to -$672.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$672.6 million, marking a year-over-year decrease of 5397.07%. This contributed to the annual value of -$467.2 million for FY2024, which is 1669.79% down from last year.
- Per Harmony Biosciences Holdings' latest filing, its Enterprise Value stood at -$672.6 million for Q3 2025, which was down 5397.07% from -$565.3 million recorded in Q2 2025.
- In the past 5 years, Harmony Biosciences Holdings' Enterprise Value ranged from a high of -$141.2 million in Q1 2021 and a low of -$672.6 million during Q3 2025
- For the 5-year period, Harmony Biosciences Holdings' Enterprise Value averaged around -$362.4 million, with its median value being -$370.7 million (2023).
- Per our database at Business Quant, Harmony Biosciences Holdings' Enterprise Value skyrocketed by 1444.76% in 2021 and then plummeted by 6223.33% in 2022.
- Quarter analysis of 5 years shows Harmony Biosciences Holdings' Enterprise Value stood at -$234.3 million in 2021, then tumbled by 56.29% to -$366.2 million in 2022, then fell by 9.32% to -$400.3 million in 2023, then decreased by 16.7% to -$467.2 million in 2024, then crashed by 43.96% to -$672.6 million in 2025.
- Its Enterprise Value was -$672.6 million in Q3 2025, compared to -$565.3 million in Q2 2025 and -$507.0 million in Q1 2025.